Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ibuprofen versus dexamethasone premedication for inferior alveolar nerve block success in irreversible pulpitis
IRCT20240830062905N1Phase 3Completed
- Sponsor
- Watim Medical and Dental College
- Start
- Jun 2023
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial in irreversible pulpitis comparing Ibuprofen premedication with Dexamethasone premedication (2 arms). Primary endpoint: Pain reduction and block success within 4 hours. Started Jun 2023; status: completed.
02
Drugs
ibuprofendexamethasone
03
Conditions
irreversible pulpitis
Beyond the preview
Go deeper on IRCT20240830062905N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20240830062905N1.